Comparative analysis of behaviors of two rat strains, Wistar and WAG/Rij, was performed. No behavioral differences between Wistar and WAG/Rij were found in the emotional resonance test. Disulfiram injection produced similar effects in both rat strains. Animals of the first group (with slow acquisition of emotional resonance reaction) transformed into the animals of the second group (with fast acquisition). Passive avoidance conditioning was successfully reproduced in Wistar and was significantly impaired in WAG/Rij. A low dose of disulfiram injected before or immediately after conditioning substantially improved the reproduction to a greater extent in WAG/Rij than Wistar strains thus eliminating in interstrain differences. Active avoidance conditioning was more successful in WAG/Rij than in Wistar rats However, on the next day conditioning in WAG/Rij was substantially impaired. Administration of the low dose of disulfiram or L-DOPA prior to conditioning impaired the acquisition but improved the reproduction on the following day in both strains, but disulfiram injection after conditioning improved conditioning in WAG/Rij to a greater extent than in Wistar. Thus, the pharmacologic enhancement of the reward system substantially changed animal behavior and improved memory consolidation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Potential of the pharmacological inhibition of CCL2-CCR2 axis via targeting FROUNT to prevent the initiation and the progression of intracranial aneurysms in rats.
J Neuropathol Exp Neurol
February 2025
Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Article Synopsis
- Intracranial aneurysms (IAs) are a significant health issue, affecting 1%-5% of the population and leading to serious conditions like subarachnoid hemorrhage, with no current medical treatments available to prevent their rupture or progression.
- Recent research proposes that IAs are linked to chronic inflammation, specifically due to macrophages entering the brain arteries through the CCL2-CCR2 signaling pathway, which is influenced by a regulator called FROUNT.
- The study shows that disulfiram, an anti-alcoholism drug, can inhibit FROUNT, reducing macrophage infiltration and thereby preventing the initiation and enlargement of IAs, as demonstrated in both lab and animal studies.
Surreptitious Administration of Disulfiram Along with Its Implantation Leading toDisulfiram-associated Encephalopathy: A Case Report.
Indian J Psychol Med
March 2024
Dept. of Psychiatry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Disulfiram is a US FDA-approved medication for the management of alcohol use disorder. However, compliance with disulfiram has been the Achilles' heel of its efficacy. Implantation and surreptitious administration of disulfiram are two methods occasionally used to ensure disulfiram compliance.
View Article and Find Full Text PDFDisulfiram-induced psychosis still an important clinical entity: A case series.
Ind Psychiatry J
August 2024
Department of Psychiatry, INHS Asvini, Mumbai, Maharashtra, India.
Disulfiram, an FDA-approved medication for treating alcohol dependence syndrome (ADS), is often used surreptitiously, resulting in severe adverse drug reactions such as disulfiram-induced psychosis (DIP). DIP presents diagnostic challenges, despite being perceived as common; however, there is limited literature available on DIP in India. We describe four cases with a history of psychosis in the background of disulfiram exposure.
View Article and Find Full Text PDFCharacterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone.
Drug Metab Dispos
October 2024
Faculty of Pharmaceutical Sciences, Kanazawa University, Japan.
Article Synopsis
- - Pirfenidone (PIR) is a drug for idiopathic pulmonary fibrosis that gets metabolized in the liver, primarily into 5-carboxylpirfenidone (5-COOH PIR), which is excreted in urine.
- - This study found that the conversion of 5-hydroxypirfenidone (5-OH PIR) to 5-COOH PIR involves alcohol dehydrogenases (ADHs), particularly ADH4, which efficiently catalyzes this process alongside other enzymes sensitive to disulfiram.
- - Individual differences in the levels and functions of these metabolic enzymes could explain varying responses to pirfenidone treatment among different patients.
Circadian chronotherapies of coronary heart disease and its biological risk factors: A United States Prescribers' Digital Reference-based review.
Chronobiol Int
November 2024
Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, Texas, USA.
Chronotherapy is the timing of medications to circadian rhythms to optimize beneficial and minimize adverse outcomes. We reviewed the US Online Prescribers' Digital Reference for the specified administration schedule of medications prescribed to manage coronary heart disease (CHD) and its major risk factors. For arterial hypertension, dosing of terazosin and guanfacine is recommended in the evening and thiazide, thiazide-like, and sulfonamide diuretics morning; Verapamil (Verelan®) morning, its "PM" formulation evening, and long-acting diltiazem (Cardizem® LA), per clinical goal, morning or evening.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!